Results for tag: "Bradykinesia Drug"

Bradykinesia is a type of musculoskeletal disorder characterized by slow, impaired movement. Bradykinesia drugs are used to treat this condition, and are typically prescribed alongside other medications to improve motor function. These drugs work by increasing the amount of dopamine in the brain, which helps to improve movement. Commonly prescribed bradykinesia drugs include levodopa, amantadine, and anticholinergics. The bradykinesia drug market is highly competitive, with a range of companies offering different products. Many of these companies are focused on developing new drugs to treat the condition, as well as providing existing treatments. Companies in the market include AbbVie, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more